Keytruda sales power Merck to quarterly beat

Harvard, Merck Collaboration Aims to Discover New Immuno-oncology Targets

“This collaborative project aims to discover and validate novel regulators of immune responses,” said Dr. Sharpe. “Immunotherapies such as checkpoint inhibitors have revolutionized the treatment of cancer, but my lab is deeply interested in understanding why some patients do not respond or develop resistance to those interventions. My hope is that by defining mechanisms that[…]

Texas almost mandated an HPV vaccine before politics got in the way. Now, the state has one of the country's highest rates of cervical cancer.

Texas almost mandated an HPV vaccine before politics got in the way. Now, the state has one of the country’s highest rates of cervical cancer.

In 2007, two governments set into motion a massive publick health experiment. One was the state of Texas, where lawmakers rejected a mandate to vaccinate adolescent girls against human papillomavirus, or HPV, […] Click here to view original web page at www.texastribune.org

4 (More) Critical Considerations For Drug Delivery Device Development

4 (More) Critical Considerations For Drug Delivery Device Development

Today, injection devices are a staple among biologic and other pharmaceutical products. With the exception of oncology products, the majority of biologic products today are launched as some form of combination product, which are stringently regulated by the FDA through 21 CFR Part 4. This article looks at important […] Click here to view original[…]

Pancreatic cancer: Less toxic, more enduring drug may improve therapy

Pancreatic cancer: Less toxic, more enduring drug may improve therapy

Unlike many other cancers, most pancreatic tumours are rock hard. “That’s one reason why pancreatic cancer is one of the most lethal types of cancer,” said Kenneth Olive, PhD, associate professor of medicine and pathology & cell biology at Columbia University Vagelos College of Physicians and Surgeons and a […] Click here to view original[…]